Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$105.23−0.20 (-0.19%)
Close on Nov 18, 2026Market cap $60.65BP/E 60.5Yield –
Edwards Lifesciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Edwards Lifesciences's shares outstanding was 578M at Jun 30, 2026. For fiscal 2025 it was 586M, down 2.3% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is 716M in fiscal 2011.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 586M | -2.3% |
| FY2024 | Dec 31, 2024 | 599M | -1.7% |
| FY2023 | Dec 31, 2023 | 609M | -2.4% |
| FY2022 | Dec 31, 2022 | 624M | -1.1% |
| FY2021 | Dec 31, 2021 | 631M | -0.1% |
| FY2020 | Dec 31, 2020 | 632M | -0.8% |
| FY2019 | Dec 31, 2019 | 637M | -0.7% |
| FY2018 | Dec 31, 2018 | 641M | -1.0% |
| FY2017 | Dec 31, 2017 | 648M | -0.9% |
| FY2016 | Dec 31, 2016 | 653M | -1.1% |
| FY2015 | Dec 31, 2015 | 661M | +1.5% |
| FY2014 | Dec 31, 2014 | 651M | -4.7% |
| FY2013 | Dec 31, 2013 | 683M | -3.8% |
| FY2012 | Dec 31, 2012 | 710M | -0.9% |
| FY2011 | Dec 31, 2011 | 716M | +0.2% |
| FY2010 | Dec 31, 2010 | 715M | +1.4% |
| FY2009 | Dec 31, 2009 | 705M | -1.4% |
| FY2008 | Dec 31, 2008 | 715M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 578M | -1.8% |
| Q1 FY2026 | Mar 31, 2026 | 581M | -1.2% |
| Q4 FY2025 | Dec 31, 2025 | 582M | -1.5% |
| Q3 FY2025 | Sep 30, 2025 | 586M | -2.1% |
| Q2 FY2025 | Jun 30, 2025 | 588M | -2.7% |
| Q1 FY2025 | Mar 31, 2025 | 588M | -2.7% |
| Q4 FY2024 | Dec 31, 2024 | 591M | -2.7% |
| Q3 FY2024 | Sep 30, 2024 | 598M | -1.9% |
| Q2 FY2024 | Jun 30, 2024 | 604M | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | 604M | -1.1% |
| Q4 FY2023 | Dec 31, 2023 | 607M | -1.5% |
| Q3 FY2023 | Sep 30, 2023 | 610M | -2.4% |
| Q2 FY2023 | Jun 30, 2023 | 610M | -2.6% |
| Q1 FY2023 | Mar 31, 2023 | 611M | -2.9% |
| Q4 FY2022 | Dec 31, 2022 | 616M | -2.5% |
| Q3 FY2022 | Sep 30, 2022 | 625M | -1.1% |
| Q2 FY2022 | Jun 30, 2022 | 627M | -0.5% |
| Q1 FY2022 | Mar 31, 2022 | 629M | -0.3% |
| Q4 FY2021 | Dec 31, 2021 | 632M | -1.5% |
| Q3 FY2021 | Sep 30, 2021 | 632M | +0.1% |
| Q2 FY2021 | Jun 30, 2021 | 630M | +1.5% |
| Q1 FY2021 | Mar 31, 2021 | 631M | -0.6% |
| Q4 FY2020 | Dec 31, 2020 | 641M | +0.5% |
| Q3 FY2020 | Sep 30, 2020 | 631M | -0.8% |
| Q2 FY2020 | Jun 30, 2020 | 620M | -2.5% |
| Q1 FY2020 | Mar 31, 2020 | 635M | -0.2% |
| Q4 FY2019 | Dec 31, 2019 | 638M | +0.2% |
| Q3 FY2019 | Sep 30, 2019 | 636M | -0.5% |
| Q2 FY2019 | Jun 30, 2019 | 636M | -0.9% |
| Q1 FY2019 | Mar 31, 2019 | 637M | -1.3% |
| Q4 FY2018 | Dec 31, 2018 | 637M | -1.4% |
| Q3 FY2018 | Sep 30, 2018 | 640M | -1.4% |
| Q2 FY2018 | Jun 30, 2018 | 642M | -0.8% |
| Q1 FY2018 | Mar 31, 2018 | 645M | -0.6% |
| Q4 FY2017 | Dec 31, 2017 | 646M | -1.3% |
| Q3 FY2017 | Sep 30, 2017 | 649M | -0.9% |
| Q2 FY2017 | Jun 30, 2017 | 647M | – |
| Q1 FY2017 | Mar 31, 2017 | 649M | – |
| Q4 FY2016 | Dec 31, 2016 | 654M | – |
| Q3 FY2016 | Sep 30, 2016 | 654M | – |
See a number that looks wrong?